Get Premium to unlock powerful stock data
NYSE:ABBV (USA)  
AbbVie Inc logo

AbbVie Inc

$ 153.93 +0.13 (+0.08%) 04:03 PM EST
P/E:
22.21
P/B:
16.80
Market Cap:
$ 272.01B
Enterprise V:
$ 337.68B
Volume:
5.46M
Avg Vol (2M):
6.47M
Also Trade In:
Volume:
5.46M
Market Cap $:
272.01B
PE Ratio:
22.21
Avg Vol (2-Month):
6.47M
Enterprise Value $:
337.68B
PB Ratio:
16.80
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%

Business Description

Description
AbbVie is a pharmaceutical company with a strong exposure to immunology and oncology. The firm's top drug, Humira, represents close to half of the company's current profits. The company was spun off from Abbott in early 2013. The recent acquisition of Allergan adds several new drugs in aesthetics and women's health.

Financials (Next Earnings Date:2022-07-29 Est.)

ABBV's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Gurus Latest Trades with NYSE:ABBV

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 56,725
EPS (TTM) ($) 6.97
Beta 0.84
Volatility % 26.34
14-Day RSI 60.84
14-Day ATR ($) 3.681599
20-Day SMA ($) 146.6415
12-1 Month Momentum % 27.8
52-Week Range ($) 105.56 - 175.91
Shares Outstanding (Mil) 1,767.11

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 6
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

AbbVie Inc Filings

Document Form Filing Date
No Filing Data

Headlines

See More